Nigel Blackburn

A Framework for Translation

Even the most promising research cannot benefit patients unless it can be guided down a successful pathway towards the clinic. Here, Andrew Davies, Professor of Haematological Oncology and Consultant Medical Oncologist at the University of Southampton, and Nigel Blackburn, Cancer Research UK’s Director of Drug Development, discuss a partnership that focuses on one crucial aspect of that journey: early-phase clinical trials.